-
1
A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer
Published 2024-11-01Subjects: “…|pembrolizumab|xelox regimen|chemotherapy|advanced gastric cancer|immunosuppression…”
Get full text
Article -
2
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Published 2025-01-01Subjects: “…cancer immunosuppression…”
Get full text
Article -
3
Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Published 2025-01-01Subjects: “…cancer immunosuppression…”
Get full text
Article